Soc. Generale Knock-Out AKAM/ DE000SN3ENA1 /
17/05/2024 21:38:59 | Var.-0.110 | Denaro21:59:33 | Lettera- | Sottostante | Prezzo di esercizio | Expiration date | Tipo di opzione |
---|---|---|---|---|---|---|---|
1.780EUR | -5.82% | 1.740 Quantità in denaro: 1,800 |
- Quantità in lettera: - |
Akamai Technologies ... | 76.5952 USD | 31/12/2078 | Call |
GlobeNewswire
00:11
ROSEN, NATIONAL TRIAL LAWYERS, Encourages Altimmune, Inc. Investors to Secure Counsel Before Importa...
GlobeNewswire
00:00
ADSK Investor Alert: Contact Kessler Topaz Meltzer & Check, LLP About the Securities Fraud Class Act...
GlobeNewswire
17/05
NCLA Tells Department of Education Its Newest Student Loan Debt Cancellation Plan Is Unlawful
GlobeNewswire
17/05
SHAREHOLDER ALERT: Levi & Korsinsky, LLP Notifies Investors of an Investigation into the Fairness of...
GlobeNewswire
17/05
Lincoln National Corporation investors: Please contact the Portnoy Law Firm to recover your losses; ...
GlobeNewswire
17/05
IntelGenx Initiates Restructuring Proceedings Under the CCAA to Implement a Review of its Strategic ...
GlobeNewswire
17/05
Iovance Biotherapeutics Reports Inducement Grants under NASDAQ Listing Rule 5635(c)(4)
Newsfile Corp
17/05
Experience the Illicit Romance of 19th-Century with B.D. Anderson's "Forbidden Desires"
GlobeNewswire
17/05
Altus Group Terminates Proposed Acquisition of Situs Group’s Commercial Real Estate Valuation Servic...
GlobeNewswire
17/05
Achilles Therapeutics Receives Nasdaq Deficiency Notice Regarding Minimum Bid Price Requirement
GlobeNewswire
17/05
AKRO Investor Alert: Kessler Topaz Meltzer & Check, LLP Urges Akero Therapeutics, Inc. Investors wit...